Meeting a microbe in the morning or in the evening: Is it all the same?

12-Sep-2017 - Canada

Does the time of day matter when our body is infected by a parasite? According to new research from McGill University, it matters a great deal.

Our body works differently at different times of the day following our internal clocks. Researchers from McGill University and the Douglas Mental Health University Institute have now established that parasitic infections are also controlled by these clocks. The severity of a microbe's infection will thus vary whether it is encountered during the day or at night, a discovery that scientists believe could pave the way to new treatment and prevention strategies for parasitic infections.

Nicolas Cermakian, a professor at McGill's Department of Psychiatry and researcher at the Douglas Institute, made the discovery using Leishmania, a parasite that causes leishmaniasis and that is transmitted at night by the female sandfly. Every year, Leishmania infects about 1 million people, killing thousands and leaving many others with scars. Although the parasite is mostly located in tropical areas, climate change could spread Leishmania far beyond where it is found today. The parasite has already spread to certain parts of southern Europe.

When mice were injected with the parasite, Professor Cermakian's team discovered that their immune response varied greatly depending on what time of day the infection occurred.

"Our previous work showed that our immune system has its own biological clocks. Our body's defence mechanisms are more or less active at different times of the day," says Nicolas Cermakian, lead author of the new study published in Scientific Reports in collaboration with McGill/RI-MUHC Professor Martin Olivier and Professor Nathalie Labrecque of Université de Montréal and Maisonneuve-Rosemont Hospital research centre.

Silke Kiessling, a former postdoctoral student in Professor Cermakian's lab, found that Leishmania's infection was more effective in the early night, a time when the immune response to the parasite was the strongest.

But why would the parasite be transmitted by a fly that bites at the exact time when our defences are at their strongest? Simply put, the parasite thrives when it elicits a strong immune response, attracting inflammatory cells it uses to multiply (macrophages and neutrophils) to the infection site.

"We already knew that viral and bacterial infections were controlled by our immune system's circadian rhythms, but this is the first time this is shown for a parasitic infection, and for a vector-transmitted infection," Professor Cermakian adds.

Tools for better treatment and prevention

Professor Cermakian's team will now try to better define how Leishmania's circadian rhythm is controlled at the molecular and cellular levels. As a first step, they already found that the clock within cells of the immune system is directing the daily rhythm of response to Leishmania.

A better understanding of how the circadian clock controls Leishmania infection could contribute to the development of new therapeutics and better prevention approaches. Working out how time regulation of host-parasite interactions are controlled, Cermakian says, might also be useful in the fight against other diseases transmitted by insects.

Original publication

Other news from the department science

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

Last viewed contents

UCB receives CHMP positive opinion on bringing Neupro back to all patients in Europe - CHMP recommends lifting of treatment restrictions for Neupro in Europe

Paion initiates programme of next generation plasminogen activators

A macromolecular shredder for RNA

A macromolecular shredder for RNA

Study links vitamin D to lung cancer survival - U-M researchers find high levels of enzyme that blocks vitamin D can predict lung cancer survival, U-M study finds

Iowa State researchers looking for catalyst that allows plants to produce hydrocarbons

Affitech Gains Exclusive Worldwide Rights to Develop and Commercialize New Anti-VEGF Antibodies

CRISPR treats genetic disorder in adult mammal

Avastin Approved in Europe for First-line Treatment of Patients With Advanced Lung Cancer - First Medicine Shown to Extend Survival Beyond One Year in Previously Untreated Lung Cancer Patients

A Potential New Therapeutic Approach for Curing Neurodegenerative Diseases - Reactivating Damaged Motor Neurons Using Magnetic Fields

A Potential New Therapeutic Approach for Curing Neurodegenerative Diseases - Reactivating Damaged Motor Neurons Using Magnetic Fields

PTC Therapeutics and Genzyme Corporation Announce Preliminary Results from the Phase 2b Clinical Trial of Ataluren

Hummingbird Diagnostics and Saarland University Collaborate in Early Disease Detection Based on Molecular Markers

Benefits of combined hormonal contraceptives continue to outweigh risks - Product information to be updated to help women make informed decisions about their choice of contraception